Catastrophic antiphospholipid syndrome in lupus-associated immune thrombocytopenia treated with eltrombopag A case series and literature review

Eltrombopag, a thrombopoietin receptor (TPO-R) agonist, is considered a second-line treatment for patients with refractory immune thrombocytopenia (ITP). Systemic lupus erythematosus (SLE) is frequently associated with ITP. In some cases, thrombocytopenia in SLE patients is attributed to concurrent...

Descripción completa

Detalles Bibliográficos
Autores principales: Garra, Wakar, Carmi, Or, Kivity, Shaye, Levy, Yair
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
6900
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9907943/
https://www.ncbi.nlm.nih.gov/pubmed/36820549
http://dx.doi.org/10.1097/MD.0000000000032949

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9907943/
https://www.ncbi.nlm.nih.gov/pubmed/36820549
http://dx.doi.org/10.1097/MD.0000000000032949

Ejemplares similares